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cGMP is critical to a variety of cellular processes, but
the available tools to interfere with endogenous
cGMP lack cellular and subcellular specificity. We
introduce SponGee, a genetically encoded chelator
of this cyclic nucleotide that enables in vitro and
in vivo manipulations in single cells and in biochem-
ically defined subcellular compartments. SponGee
buffers physiological changes in cGMP concen-
tration in various model systems while not affecting
cAMP signals. We provide proof-of-concept strate-
gies by using this tool to highlight the role of
cGMP signaling in vivo and in discrete subcellular
domains. SponGee enables the investigation of local
cGMP signals in vivo and paves theway for therapeu-
tic strategies that prevent downstream signaling
activation.INTRODUCTION
Cyclic guanosine monophosphate (cGMP) is a second
messenger involved in a wide range of signaling pathways and
cellular processes, including neurotransmission, calcium ho-
meostasis, phototransduction, lipid metabolism, and cation
channel activity (Averaimo and Nicol, 2014; Koch and Dell’Orco,
2015; Koesling et al., 2016; Kuhn, 2016). The diversity of these
processes suggests that cGMP signals are tightly controlled in
space and time to achieve specificmodulation of its downstream
pathways (Castro et al., 2006; Stangherlin et al., 2011). However,
manipulating cGMP is usually achieved using pharmacological
approaches that either alter the synthesis or degradation of
this cyclic nucleotide or interfere with downstream signaling
pathways (Brescia and Zaccolo, 2016; Poppe et al., 2008). These
strategies lack both cellular and subcellular specificity. Recently,
optogenetic strategies have emerged to impose acute and
extrinsic modulation of cGMP or reduce its concentration and
to investigate the dynamics of cGMP signaling (Gao et al.,Cel
This is an open access article under the CC BY-N2015; Ryu et al., 2010). However, these light-sensitive tools are
handicapped in vivo, when light stimulation is technically chal-
lenging (e.g., during developmental stages). In addition, photo-
activatable guanylyl cyclases do not prevent endogenous
cGMP signals ,and the available light-sensitive phosphodiester-
ases exhibit low specificity for cGMP and degrade the closely
related nucleotide cyclic AMP (cAMP) (Gasser et al., 2014; Yosh-
ida et al., 2017). This is a serious drawback because cAMP and
cGMP regulate a wide range of signaling pathways and cellular
processes that are often modulated by both signaling molecules
(e.g., axon pathfinding is dependent on both cAMP and cGMP,
which have opposite effects) (Akiyama et al., 2016; Nishiyama
et al., 2003; Shelly et al., 2010). These shared regulations make
critical the need of tools controlling each cyclic nucleotide with
specificity. Genetically encoded tools that monitor or manipulate
the concentration of cAMP have fueled the transition from the
alteration of this second messenger signals without cellular
and subcellular control to the investigation of spatial and tempo-
ral codes enabling specificity for its downstream pathways and
cellular processes (Averaimo et al., 2016; Lefkimmiatis et al.,
2009). The cGMP field is still lacking these essential tools to un-
derstand how this ubiquitous secondmessenger achieves spec-
ificity for its myriad of downstream effectors. An attempt has
been made with endless, an RNA motif that binds cGMP (Kröner
et al., 2014). However, endless does not enable subcellular con-
trol of cGMP manipulation. Expanding this toolbox to peptidic
sequences would allow for alteration of physiological variations
of cGMP with cellular and subcellular specificity in vitro and
in vivo. The ideal tool with which to manipulate cGMP signaling
would (1) prevent the activation of downstream effectors and
cGMP-dependent cellular processes; (2) interact directly with
cGMP, rather than modifying the activity of cGMP-synthetizing
or degrading enzymes; (3) be specific for cGMP over cAMP; (4)
be genetically encoded to achieve cellular specificity and enable
selective subcellular localization by using fusion to target se-
quences; and (5) allow cellular identification with fluorescent
reporters. We provide here the description of SponGee
(sponge-inhibiting cGMP signaling), a cGMP-specific scavenger
that fulfills these requirements. Using a FRET sensor we
developed, we show that SponGee alters cGMP but not cAMPl Reports 27, 4003–4012, June 25, 2019 ª 2019 The Authors. 4003
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. SponGee Dimerizes and Binds cGMP
(A) SponGee contains the cGMP binding domains and leucine zipper of a high-
affinity PKG1a/PKG1b chimera (Ruth et al., 1997) and is fused to mRFP to
enable cell identification. The effector domains of PKG are deleted in SponGee
to avoid the activation of downstream effectors.
(B) SponGee was detected close to its expected monomer molecular weight
(67 kDa) under reducing conditions, but at twice this size when DTT was
omitted.
(C) The anisotropy of fluorescence emitted by 3.2 nM of Fluo-cGMP exposed
to increasing concentration of SponGee was fitted to measure the affinity of
SponGee for this cGMP analog.
(D) The fluorescence anisotropy of a mix containing 3.2 nM of Fluo-cGMP,
2 mM of SponGee, and increasing concentrations of cGMP was fitted to
determine the dissociation constant of unmodified cGMP.
Number of replicates are provided in Table S1.signals, has distinct actions depending on its subcellular locali-
zation, perturbs axon pathfinding in vitro, and disturbs neuronal
migration in vivo. Because cGMP is a signaling component
shared by bacteria (Marden et al., 2011; Ryu et al., 2015) and eu-
karyotes, this tool will be broadly applicable in a wide range of
experimental model systems.RESULTS
SponGee Buffers Elevations of cGMP
The design of SponGee is based on a high-affinity chimeric
variant of the bovine cGMP-dependent protein kinase (PKG)
containing fragments of PKG1a and PKG1b (Ruth et al., 1997).
SponGee contains the binding sites and chimeric affinity domain
of PKG while excluding the kinase domain to prevent the activa-
tion of downstream effectors (Figure 1A). The sequence of
SponGee is provided in the STAR+Methods section. We further
fused the construct to mRFP fluorescent protein for easy
identification of SponGee-expressing cells. We favored a PKG-
derived scavenger rather than a phosphodiesteterase-based
enzyme that would degrade cGMPbecause of the low specificity
of phosphodiesterase-based tools for cGMP over cAMP (Gasser
et al., 2014; Yoshida et al., 2017). PKG ability to bind cGMP re-
quires dimerization, a process relying on the leucine zipper of4004 Cell Reports 27, 4003–4012, June 25, 2019PKG (Kim et al., 2016). This domain is conserved in SponGee.
To explore the possibility of SponGee expression as dimers,
cellular extracts of HEK293 cells expressing SponGee were
analyzed by SDS-PAGE under non-reducing or reducing condi-
tions. In the presence of DTT, SponGee was detected close to its
expected monomer size (67 kDa). Under non-reducing condi-
tions, a band corresponding to twice this molecular weight
was found, suggesting that SponGee forms dimers (Figure 1B).
To characterize its affinity for cGMP, SponGee was expressed
in Escherichia coli and purified. The dissociation constant was
evaluated using fluorescence anisotropy of Fluo-cGMP. The
KD of SponGee for Fluo-cGMP was determined (KD = 1.7 ±
0.2 mM; Figure 1C), before using a competitive assay to measure
the affinity of unmodified cGMP for SponGee (KD = 0.97 ±
0.26 mM; Figure 1D). Note that because the fluorescence titration
data did not exhibit any evidence for two binding sites with
different affinities (Figures 1C and 1D), the KD was computed
assuming a single binding site. With the hypothesis of two sites
of similar affinities, the KD of each site would be 1.94 ± 0.52 mM
with the following apparent dissociation constant for the entire
SponGee protein: KD = 0.97 ± 0.26 mM.
SponGee buffering properties in living cells were investigated
using ThPDE5VV, a FRET sensor for cGMP that we developed.
ThPDE5VV is similar to cGES-DE5, a previously described
cGMP biosensor (Nikolaev et al., 2006). The donor and acceptor
fluorescent proteins of cGES-DE5 have been replaced by their
optimized variants mTurquoise and a tandem of mVenus,
respectively, following a previously described strategy (Klaren-
beek et al., 2011). The emission spectrum (434/10 nm excitation)
of lysates of HEK293 cells expressing ThPDE5VV exhibit a shift
when in the presence of 200 mM of cGMP, with increased yellow
fluorescent protein (YFP) and reduced CFP emission (Fig-
ure S1A). The half maximal effective concentration (EC50) of
ThPDE5VV for cGMPwasmeasured from lysates of HEK293 cells
expressing the biosensor (EC50 = 0.32 ± 0.09 mM; Figure S1B).
The same procedure was used to measure the EC50 for cAMP
(EC50 = 1.6 ± 0.7 mM; Figure S1B), highlighting the specificity
of this sensor for cGMP over cAMP. ThPDE5VV was expressed
in vitro in rat hippocampal neurons exposed to DEA-NONOate,
a donor of nitric oxide (NO), which activates cGMP synthesis
by SGCs (Bhargava et al., 2013). The elevation of cGMP con-
centration induced by DEA-NONOate led to a rise of the
FRET:CFP ratio in ThPDE5VV-expressing neurons, validating
the use of ThPDE5VV as a cGMP biosensor (Figures S1C and
S1D). In contrast, the adenylyl cyclase activator forskolin did
not modify the FRET:CFP ratio, confirming the specificity of
ThPDE5VV for cGMP over the closely related cyclic nucleotide
cAMP (Figure S1). HEK293 cells were used to further validate
ThPDE5VV as a cGMP sensor. Although overexpression is
generally used to investigate soluble guanylyl cyclase (sGC) ac-
tivity using this cell line (Mullershausen et al., 2004; Wobst et al.,
2016), both a and b subunit of sGC1 are expressed in HEK293
cells (Figure S2A). Spermine-NONOate, a donor of NO that
activates sGCs, induces an increase in the phosphorylation of
VASP at serine 239, a downstream event of cGMP signaling.
p239VASP elevation is reduced when HEK293 cells are incubated
in the sGC inhibitor ODQ (Figure S2B), confirming the presence
of sGC activity in HEK293 cells. Like hippocampal neurons,
Figure 2. SponGee Is a cGMP Scavenger
(A) A 1-min exposure of 50 mM spermine-NONOate (NO) induces an increase
in the cGMP concentration of control HEK293 cells, monitored by the
FRET:CFP ratio from the FRET biosensor ThPDE5VV (B and D, blue trace)
(see also Video S1). This elevation is drastically reduced when cells express
SponGee (B and D, orange trace) (see also Video S1) but not when a variant
of SponGee mutated at both cGMP binding sites is expressed (MutSponGee,
D, purple trace). FRET ratio is coded from blue (low cGMP) to red (high
cGMP).
(C and E) The red image (RFP) indicates the expression level of the SponGee-
RFP fusion protein. Both the amplitude and rising speed of cGMP elevation are
reduced by expression of (C) SponGee but not (E) its mutated form.
(F) NO (50 mM Spermine-NONOate) exposure leads to a p239VASP increase
that is reduced by SponGee expression. Scale bar, 15 mm.
(B and D) Data are mean ± SEM. (C and E) Box-and-whisker plot elements:
center line, mean; box limits, upper and lower quartiles; whiskers, SD; mean
values for single coverslips (circles) are shown to check for nesting effects. (F)
Data are mean ± SEM. Values for individual experiments are shown. (C) ***p <
0.001; Mann-Whitney tests. (F) ***p < 0.001; **p < 0.01; one-way ANOVA and
Newman-Keuls post hoc tests. Exact p values and number of replicates are
provided in Table S1. CFP and YFP traces together with individual cell ex-
amples are provided in Figure S7.
See also Figures S1, S2, and S3.ThPDE5VV-expressing HEK293 cells exhibited an increase in the
FRET:CFP ratio when exposed to a short pulse of spermine-
NONOate, revealing an elevation in intracellular cGMP concen-
tration (Figures 2A and 2B; Figure S2; Video S1). The cGMP
elevation detected by ThPDE5VV is reduced by the pharmacolog-
ical blockade of sGC activity using ODQ (Figures S2C and S2D).
These observations demonstrate that the signal detected by
ThPDE5VV relies on sGC activity. To further confirm that
ThPDE5VV is a cGMP sensor, a previously described FRET
probe, cGi500, was used (Russwurm et al., 2007). cGi500-
expressing HEK293 cells exhibited an elevation in the CFP:FRET
ratio of reduced amplitude compared to ThPDE5VV after a 1-min
pulse of NO exposure (Figures S2E and S2F). The reversibility of
the FRET change of ThPDE5VV was complete, in contrast to
cGi500 that did not reach its basal CFP:FRET ratio after the
wash of NO (Figures S2E and S2G).
In the absence of SponGee, a 1-min pulse of spermine-
NONOate induced an increase in the FRET:CFP ratio of
ThPDE5VV with a 1-min delay since the start of the stimulation
(Figures 2A–2C; Video S1). SponGee expression resulted in
a profound reduction of the spermine-NONOate-induced
FRET:CFP change, reflecting a decrease in cGMP molecules
available to bind the biosensor (Figures 2A–2C; Video S1). To
verify that the activity of SponGee is linked to its cGMP binding
sites, both binding domains were mutated following a previously
used strategy to prevent cAMP binding to the cyclic nucleotide
binding domain of PKA (Lefkimmiatis et al., 2009): the glycine
residues at positions 247 and 299 were converted into glutamic
acid. These two point-mutations were sufficient to abolish the
reduction in the FRET response induced by SponGee (Figures
2D and 2E), excluding the possibility that SponGee is a NO
scavenger through cysteine nitrosylation or the formation of di-
sulfide bonds in SponGee. It also excludes the possibility that
the detected FRET variation is due to disulfide bonds in other
proteins, including the FRET sensor. To evaluate whether
the SponGee-induced reduction in the FRET amplitude is trans-
ferable to other cGMP FRET sensors, we reproduced similar ex-
periments with cGi500. Like ThPDE5VV, cGi500 enabled the
detection of a NO-induced cGMP elevation in HEK293 cells,
which was reduced when SponGee was co-expressed (Figures
S3A and S3B). SponGee expression is also sufficient to reduce
NO-induced VASP phosphorylation (Figure 2F). These observa-
tions demonstrate that SponGee works as a cGMP scavenger
and reduces the availability of this second messenger for its
downstream pathway activation. It also highlights that SponGee
is more effective in scavenging cGMP than the binding domains
of both ThPDE5VV and cGi500 because it competes with these
biosensors to bind the available cGMP and that the cGMP-
induced changes in the FRET ratio is reduced by SponGee
expression. Because cGMP scavenging relies on the availability
of the cGMP binding sites, the intracellular concentration of
SponGee might strongly affect its efficiency to reduce endoge-
nous cGMP signals due to the saturation of the binding pockets.
To evaluate the impact of the expression level, single-cell
SponGee concentration was estimated using the fluorescence
intensity of the fused mRFP and plotted against the amplitude
of the FRET ratio for individual cells. Although a few cells with
the lowest expression of SponGee exhibited low or no cGMPCell Reports 27, 4003–4012, June 25, 2019 4005
Figure 3. SponGee Reduces the Elevation of cGMPConcentration Induced by a Prolonged Pulse of Spermine-NONOate and Delays Massive
and Sustained Elevations of Intracellular cGMP Concentration
(A) HEK293 cells were exposed to a 2-min pulse of 50 mM spermine-NONOate.
(B and C) SponGee-expressing cells (B, orange trace) display (C) a reduction of both the FRET:CFP ratio amplitude and the rate of increase compared to controls
(also see Video S2).
(D) A 15-min pulse of 50 mM spermine-NONOate induces a massive change in the ThPDE5VV FRET:CFP ratio.
(E and F) Cells expressing SponGee (E, orange trace) exhibit a change in the FRET:CFP ratio (F) of similar magnitude, but delayed as compared to cells devoid of
SponGee (E, blue trace; also see Video S3). Scale bar, 20 mm.
(B and E) Data are mean ± SEM. (C and F) Box-and-whisker plot elements: center line, mean; box limits, upper and lower quartiles; whiskers, SD; mean values for
single coverslips (circles) are shown to check for nesting effects. *p < 0.05, ***p < 0.001; Mann-Whitney test. Exact p values and number of replicates are provided
in Table S1. CFP and YFP traces together with individual cell examples are provided in Figure S7.buffering, the reduction the ratio elevation was observed in
most cells, including those with low mRFP fluorescence
(Figure S3C).
To investigate the limits of cGMP buffering by SponGee, cells
co-expressing SponGee and ThPDE5VV were exposed to longerFigure 4. SponGee Does Not Affect Cell Survival
(A) HEK293 cells were transfected with either SponGee or RFP. Activated
Caspase 3-positive cells were immunolabeled to evaluate the number of cells
undergoing apoptosis.
(B) SponGee-expressing cells are not more prone to enter an apoptotic pro-
gram than their RFP-expressing controls.
(A) Scale bar, 50 mm. (B) Data are mean ± SEM with individual data points,
Mann-Whitney test. Exact p values and number of replicates are provided in
Table S1.
4006 Cell Reports 27, 4003–4012, June 25, 2019spermine-NONOate stimulation (2-min pulse or sustained
exposure). Expressing SponGee was sufficient to reduce both
the amplitude and delay of the FRET:CFP elevation induced by
a 2-min exposure to spermine-NONOate (Figures 3A–3C; Video
S2). In contrast, the cGMP elevation detected by ThPDE5VV dur-
ing a sustained spermine-NONOate stimulation was delayed,
but the peak amplitude was only moderately reduced (Figures
3D–3F; Video S3). This suggests that massive and prolonged in-
crease in cGMP concentration leads to the saturation of Spon-
Gee or ThPDE5VV cGMP binding sites.
SponGee Is Not Cytotoxic
The chronic scavenging of cGMP might affect cell survival
because of the role of this second messenger in many
signaling pathways and cellular processes. However, the
morphology of SponGee-expressing cells did not differ from
their control, suggesting that cell death was not affected
(Figure 4A). Activated Caspase 3 was immunostained to eval-
uate the fraction of apoptotic cells. Caspase 3 was not
activated in SponGee-expressing HEK293 cells, confirming
that buffering cGMP with SponGee does not affect cell sur-
vival (Figure 4).
SponGee Is Specific for cGMP Over cAMP
To evaluate the specificity of SponGee for cGMP over the
closely related cAMP, we conducted FRET experiments by
using a previously described and validated cAMP biosensor,
Figure 5. SponGee Is Highly Specific for
cGMP Over cAMP
(A) HEK293 cells were exposed to a 20-s pulse of
10 mM Fsk under constant 10 mM ODQ perfusion.
(B and C) The SponGee-positive cells (B, orange
trace) co-expressing the cAMP biosensor H147
display (C) a similar CFP:FRET ratio amplitude and
rate of increase compared to controls (B, blue
trace; also see Video S4).
(D) Cells were exposed to 10 mM Fsk to elevate
their cAMP concentration and challenge the ability
of SponGee to discriminate between cGMP and
cAMP. Fsk-elevated cAMP concentration did not
prevent SponGee (E, orange trace) to reduce (F)
the amplitude and rate of increase of the 50 mM
Spermine-NONOate-induced cGMP signal de-
tected by the cGMP sensor ThPDE5VV (also see
Video S5).
(G) A second set of experiments was carried out to
compare the reduction of cGMP elevation in
presence or absence of 10 mM Fsk.
(H and I) Fsk exposure (H, top) does not reduce (I)
the ability of SponGee to buffer cGMP elevation.
Scale bar, 20 mm.
(B, E, and H) Data are mean ± SEM. (C, F, and I)
Box-and-whisker plot elements: center line, mean;
box limits, upper and lower quartiles; whiskers,
SD; mean values for single coverslips (circles) are
shown to check for nesting effects. ***p < 0.001;
Mann-Whitney test. Exact p values and number of
replicates are provided in Table S1. CFP and YFP
traces together with individual cell examples are
provided in Figure S7.H147 (Averaimo et al., 2016; Klarenbeek et al., 2015). In many
systems, cAMP and cGMP signaling influence each other,
with the concentration of both cyclic nucleotides changing in
opposite directions (Averaimo and Nicol, 2014; Pietrobon
et al., 2011; Shelly et al., 2010; Zaccolo and Movsesian,
2007). To minimize the influence of cGMP scavenging by
SponGee on cAMP measurements, the cAMP buffering
activity of SponGee was evaluated in cells with pharmacolog-
ically reduced and stabilized cGMP concentration. RFP- or
SponGee-expressing cells were maintained with reduced
cGMP-signaling by using the sGC inhibitor ODQ and later
exposed to a 20-s pulse of the adenylyl cyclase activator For-
skolin (Fsk). SponGee did not reduce the amplitude or induce
a delay in the elevation of cAMP concentration (Figures 5A–
5C; Video S4). We evaluated whether high intracellular con-
centrations of cAMP can bind and saturate the cGMP-binding
domains of SponGee, reducing its ability to act as a cGMP-
specific scavenger. SponGee is still able to efficiently buffer
NO-induced cGMP elevation while cAMP concentration is
increased by Fsk (Figures 5D–5F; Video S5). An additional
set of experiments was carried out to evaluate whether the
reduction in the FRET:CFP ratio is similar with and
without cAMP elevation. Fsk exposure does not affect theCell RSponGee-induced reduction in the
cGMP signal, showing that cellular
cAMP does not prevent SponGee tobuffer cGMP, even in a cellular environment with high cAMP
concentrations (Figures 5G–5I). These observations demon-
strate that SponGee does not buffer intracellular cAMP and
highlight its specificity for cGMP.
SponGee Reveals the Requirement of cGMP for
Neuronal Migration In Vivo
To evaluate the ability of SponGee to interfere with physiolog-
ical processes in vivo and, thus, assess its potential as a tool
to investigate cellular function in an intact organism, SponGee
was electroporated in utero in the brain lateral ventricles of
embryonic day 14.5 (E14.5) mouse embryos. The migration
of electroporated cortical neurons was analyzed at E18.5
and P10. In E18.5 control eGFP and mRFP co-electroporated
animals, neurons display an archetypical migration with the
majority of transfected cells accumulating in the cortical plate
near the marginal zone (Figures 6A and 6B). In contrast,
neurons co-electroporated with SponGee and GFP exhibit a
delayed migration, with neurons scattered throughout the
cortical plate, including the intermediate zone (Figure 6A). In
addition, several electroporated cells failed to stall at the
cortical plate, overshooting the terminal zone observed in
mRFP-electroporated controls (Figure 6B). Heterotopiaseports 27, 4003–4012, June 25, 2019 4007
Figure 6. SponGee Alters Cortical Neuron Migration In Vivo
(A and B) Control cortical neurons electroporated at E14.5 are packed into a
dense layer close to the marginal zone at E18.5. In contrast, SponGee
expression prevents the development of this layer, with (A) neurons scattered
throughout the depth of the developing cortex (arrowhead) and (B) the for-
mation of heterotopias (arrowhead) at the surface of the cortex.
(C) At P10, SponGee-electroporated neurons and their mRFP-electroporated
controls are both found in the superficial layers of the cortex. The inset shows
mRFP fluorescence, highlighting that SponGee is still expressed at P10.
(D) Heterotopias induced by SponGee at embryonic stages are maintained in
P10 pups (arrowhead), indicating that altering cGMP signaling interferes with
cortical neuron migration. Box-and-whisker plot elements: center line, mean;
box limits, upper and lower quartiles; whiskers, SD.
Scale bars, (A) 250 mm, (B) 100 mm, (C) 500 mm, (D) 200 mm. **p < 0.01; Two-
way ANOVA and Bonferroni post hoc tests. Exact p values and number of
replicates are provided in Table S1.were found in 7 out of 9 SponGee-electroporated animals,
whereas 2 out of 10 mRFP-expressing embryos exhibited
neurons overshooting the cortical plate (p = 0.000037, c2
test). Misplaced SponGee-expressing neurons were still found
at P10 with heterotopias in 71% of the pups (5 out of 7) as
compared to 20% control animals (1 out of 5, p = 0.000024,
c2 test) (Figures 6C and 6D). This demonstrates that cGMP
buffering by SponGee is sufficient to alter the physiological
cGMP modulation required for the appropriate neuronal
migration in vivo.4008 Cell Reports 27, 4003–4012, June 25, 2019Subcellular Targeting of SponGee Reveals Local cGMP
Signaling during Axon Pathfinding
To achieve specific activation of its plethoric downstream targets,
cGMP signals are confined to specific subcellular compartments
(Castro et al., 2006; Stangherlin et al., 2011). Because genetic
encoding confers the ability to restrict the expression of the con-
structs to a specific organelle using targeting sequences, we
assessed the functionality of SponGee in this scenario. The
cGMP buffer was targeted to the plasma membrane, further re-
stricting its expression to the lipid raft microdomains by the N-ter-
minal fusion of a tandemof palmitoylation-myristoylation targeting
peptides from Lyn Kinase (Lyn-SponGee) or excluding it from the
lipid raft domain by the C-terminal fusion of a CaaX-polylysine
motif derived from K-Ras (SponGee-Kras) (Figure 7A) (Averaimo
et al., 2016; Depry et al., 2011; Zacharias et al., 2002). We
confirmed that Lyn-SponGee and SponGee-Kras expression
was restricted to the membrane in HEK293 cells, in contrast to
the untargeted SponGee (Figure 7B). We analyzed the localization
of Lyn-SponGee and SponGee-Kras in distinct membrane com-
partments in retinal neurons by using membrane fractionation in
a sucrose density gradient (Averaimo et al., 2016). Lyn-SponGee
expression was restricted to low-density fractions, concomitant
with the lipid raft marker Caveolin 1. In contrast, SponGee-Kras
was enriched in the high-density fractions togetherwithb-Adaptin,
a marker of the non-raft component of the membrane (Figures 7C
and 7D; Figure S4). To assess whether compartmentalization of
SponGee differentially affects cGMP-dependent cellular re-
sponses, we analyzed the behavior of retinal ganglion cell growth
cones expressing either Lyn-SponGee or SponGee-Kras when
exposed to the axon guidance molecules slit1 and ephrinA5.
Slit1- and ephrinA5-dependent repulsion of axonal growth cones
require cGMP signaling (Nguyen-Ba-Charvet et al., 2001; Yue
et al., 2008). The presence of a cGMP response in response to
axon repellents was verified using ThPDE5VV and ephrinA5 stimu-
lation in retinal ganglion cell axons. EphrinA5 induces an elevation
of cGMP thatwas blocked bySponGee (Figure S5). The biological
response of axons expressing the soluble or targeted variants of
SponGeeandexposed toslit1 or ephrinA5wasevaluated todeter-
mine whether targeting SponGee to distinct subcellular compart-
ments leads to differential axon behavior. In control conditions,
including untransfected axons and mRFP-electroporated axons,
slit1 and ephrinA5 induced the collapse of the growth cone (Fig-
ures 7E and 7F; Figure S6). SponGee expression in the cytosol
abolished thecollapse response inducedbybothcues, confirming
the requirement of cGMP signaling in this process. Similarly, slit1
and ephrinA5 failed to induce growth cone collapse in Lyn-Spon-
Gee-expressing axons. In contrast, SponGee-Kras-expressing
axons were indistinguishable from controls (Figures 7E and 7F;
Figure S6), demonstrating that the blockade of cGMP signaling
by SponGee in but not outside lipid rafts is sufficient to prevent
slit1- and ephrinA5-inducedgrowth conecollapse. Thus, targeting
SponGee to distinct compartments enables the control of cGMP
and its downstream signaling with subcellular resolution.
DISCUSSION
The present work introduces SponGee, a molecular scavenger of
cGMP.We show that SponGee efficiently buffers cGMP, whereas
Figure 7. Subcellular Restriction of cGMP Manipulation Using SponGee
(A) SponGee was either used to alter cGMP signaling in the entire cell when not targeted to any cellular compartment or to prevent the activation of cGMP
downstream effectors in specific compartments. Lyn-SponGee aims to be confined to lipid rafts whereas SponGee-Kras is intended to be restricted to the non-
raft fraction of the plasma membrane.
(B) SponGee is detected in the cytoplasm (top row) whereas both Lyn-SponGee and SponGee-Kras are found at the plasmamembrane (middle and bottom row).
(C) Plasma membrane fractionation highlights distinct subcellular localization of Lyn-SponGee and SponGee-Kras.
(D) Lyn-SponGee is highly enriched in fraction 4, whereas the localization of SponGee-Kras is shifted toward higher density fractions (7 to 9) (also see Figure S4).
(E and F) 200 ng$mL1 slit1 (E) and (F) 500 ng$mL1 ephrinA5 (F) induce growth cone collapse in control axons. SponGee and Lyn-SponGee prevents the collapse
of growth cone. In contrast, SponGee-Kras does not affect axonal response to slit1 and ephrinA5 (also see Figures S6). Box-and-whisker plot elements: center
line, mean; box limits, upper and lower quartiles; whiskers, SD.
Scale bars (B) 20 mM, (E) 10 mm. (C andD) *p < 0.05, **p < 0.01, ***p < 0.001; Two-way ANOVA followed by Bonferroni post hoc tests. (E and F) *p < 0.01, **p < 0.01,
***p < 0.001; Kruskal-Wallis test followed by Mann-Whitney post hoc tests. Exact p values and number of replicates are provided in Table S1.
See also Figures S4, S5, and S6.it does not interact with the closely related cAMP. Because
SponGee can be expressed in a subset of cells, the use of this
cGMP buffer enables us to investigate the role of cGMP in cellular
processes such as neuronal migration in a cell-specific manner.
Furthermore, by including a high-affinity cGMP-binding domain
of an endogenous protein, we have produced a specific and
non-cytotoxicbuffer that enables chronicmanipulationof selected
cell types. The possibility to target subcellular compartments
further increases the ability of SponGee to affect a subset of
cGMP-dependent downstream pathways with high specificity.
Incidentally, ThPDE5VV, the cGMP sensor introduced herein also
offers the possibility to study cGMP modulation in cells, with
more reversibility than the previously described cGi500.
Second messengers are key in the regulation of cellular re-
sponses to the environment and of their intrinsic behavior. Being
able to manipulate the concentration of these signaling mole-
cules in a precise and predictable fashion is crucial for the
understanding of their downstream signaling cascades and
cellular responses. Second messengers are situated at theconvergence of multiple signaling cascades. A simple view of
these signaling molecules diffusing freely in the cytosol conflicts
the specific activation of each of their downstream effectors. The
spatial confinement of second messengers emerged as a likely
regulator of cellular responses (Augustine et al., 2003; Averaimo
and Nicol, 2014; Averaimo et al., 2016). Much effort has been
devoted to the development of tools that allow the subcellular
manipulation of cAMP through genetically encoded tools (Aver-
aimo et al., 2016; Lefkimmiatis et al., 2009) and calcium by using
pharmacological agents targeting specific channels, but to date
there is no refined way to block cGMP transients in a cell-depen-
dent manner and with subcellular resolution. SponGee over-
comes the issues of current cGMP manipulating methods by
enabling both specificity for cGMP over cAMP and cellular
selectivity when combined with cell-type specific promoters
and subcellular localization when fused to known targeting se-
quences. It offers the possibility to investigate cGMP signals to
a previously unachieved degree. SponGee also offers the
opportunity to study the epistatic relationship between secondCell Reports 27, 4003–4012, June 25, 2019 4009
messengers in fields like axon guidance, where guidance mole-
cules activating apparently the same signaling cascades are
able to exert contradictive actions in developing axons (Akiyama
et al., 2016; Nishiyama et al., 2003; Shelly et al., 2010).
SponGee was able to induce abnormalities in neuronal migra-
tion and axonal response to repellent cues and to compete with
biosensors with an apparent EC50 of a few hundred nanomolar
(ThPDE5VV, 320 nM; cGi500, 500 nM, Russwurm et al., 2007),
which may seem contradictory with the described SponGee
KD obtained from overexpressing bacteria (0.97 mM). This
apparent discrepancy might reflect the impact of expressing
SponGee in E. coli rather than eukaryotic cells. SponGee folding
or post-translational modifications might be affected in bacteria
and that might reduce its ability to bind cGMP with high affinity.
The use of SponGee as a cGMP scavenger in prokaryotic
cells should be further validated. However, its ability to alter
endogenous cGMP signaling in mouse and human cells has
been extensively demonstrated here, suggesting that the affinity
of SponGee for cGMP when expressed in eukaryotic cells might
be higher inmammalian cells thanwhen overexpressed in E. coli.
In the dawn of gene therapy, SponGee rises as a potential
treatment for diseases characterized by overactivation of
cGMP signaling pathways, such as retinitis pigmentosa (Huang
et al., 1995; Vighi et al., 2018). Combining gene therapy with
cellular and subcellular targeting strategies, SponGee offers an
alternative approach enabling the specific manipulation of the
abnormal pathways without altering other cGMP-dependent
mechanisms. This targeted manipulation introduces cGMP as
a therapeutic target with a limited risk of side effects.
In conclusion, SponGee has the potential to alter cGMP re-
sponses in a cell-specific manner and with subcellular resolution
for the precise investigation of signaling cascades and opens
new perspectives for specific therapeutic interventions.STAR+METHODS
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Leterrier, C., Lainé, J., Darmon, M., Boudin, H., Rossier, J., and Lenkei, Z.
(2006). Constitutive activation drives compartment-selective endocytosis
and axonal targeting of type 1 cannabinoid receptors. J. Neurosci. 26, 3141–
3153.
Loulier, K., Lathia, J.D., Marthiens, V., Relucio, J., Mughal, M.R., Tang, S.-C.,
Coksaygan, T., Hall, P.E., Chigurupati, S., Patton, B., et al. (2009). beta1 integ-
rin maintains integrity of the embryonic neocortical stem cell niche. PLoS Biol.
7, e1000176.
Maag, D., and Lorsch, J.R. (2003). Communication between eukaryotic trans-
lation initiation factors 1 and 1A on the yeast small ribosomal subunit. J. Mol.
Biol. 330, 917–924.
Marden, J.N., Dong, Q., Roychowdhury, S., Berleman, J.E., and Bauer, C.E.
(2011). Cyclic GMP controls Rhodospirillum centenum cyst development.
Mol. Microbiol. 79, 600–615.Monestier, A., Lazennec-Schurdevin, C., Coureux, P.-D., Mechulam, Y., and
Schmitt, E. (2018). Role of aIF1 in Pyrococcus abyssi translation initiation. Nu-
cleic Acids Res. 46, 11061–11074.
Mullershausen, F., Russwurm, M., Koesling, D., and Friebe, A. (2004).
In vivo reconstitution of the negative feedback in nitric oxide/cGMP
signaling: role of phosphodiesterase type 5 phosphorylation. Mol. Biol.
Cell 15, 4023–4030.
Nguyen-Ba-Charvet, K.T., Brose, K., Marillat, V., Sotelo, C., Tessier-Lavigne,
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Cleaved Caspase 3 (Asp175) Cell Signaling Cat# 9661S, lot # 0043. RRID: AB_2341188.
Mouse anti-a-tubulin Sigma-Aldrich Cat# T6199, lot # 024M4850V. RRID: AB_477583.
Rabbit anti-b-adaptin (H-300) Santa Cruz Biotechnology Cat# sc-10762, lot # E1304. RRID: AB_2242872
Living Colors DsRed Polyclonal Antibody Clontech Cat# 632496, lot # 1306037. RRID: AB_10013483
Rabbit Anti-Caveolin Polyclonal Antibody BD Biosciences Cat# 610060, lot # GR256941. RRID: AB_397472
GUCY1A3 Monoclonal Antibody (3G6B2) Thermo Fisher Scientific Cat# MA5-17086, lot # TJ2659608. RRID: AB_2538557
GUCY1B3 Polyclonal Antibody Thermo Fisher Scientific Cat# PA5-42803, lot # TJ2266011. RRID: AB_2608158
Phospho-VASP (Ser239) Antibody Cell Signaling Technology Cat# 3114, lot # 7. RRID: AB_2213396
VASP (9A2) Rabbit mAb antibody Cell Signaling Technology Cat#3132, lot # 4. RRID: AB_2213393
GFP Tag Polyclonal Antibody Thermo Fisher Scientific Cat# A11122, lot # 1789911. RRID: AB_221569
Peroxidase-AffiniPure Goat Anti-Rabbit IgG
(H+L) antibody
Jackson ImmunoResearch Labs Cat# 111-035-003, lot # 81283. RRID: AB_2313567
Peroxidase-AffiniPure Goat Anti-Mouse IgG
(H + L) antibody
Jackson ImmunoResearch Labs Cat# 115-035-003. RRID: AB_10015289
Donkey Anti-Mouse IgG (H+L) Antibody,
Alexa Fluor 488 Conjugated
Thermo Fisher Scientific Cat# A21202, lot # 1562298. RRID: AB_141607
Donkey anti-Rabbit IgG (H+L) Highly
Cross-Adsorbed Secondary Antibody, Alexa
Fluor 594
Thermo Fisher Scientific Cat# A21207, lot # 1602780. RRID: AB_141637
Critical Commercial Assays
CellEvent Caspase-3/7 Green Detection Reagent Thermo Fisher Scientific Cat# C10723, lot # 1932830. RRID: Not available
Experimental Models: Cell Lines
HEK293 ATCC Cat# CRL-1573. RRID: CVCL_0045
Experimental Models: Organisms/Strains
Mus musculus C57BL/6JRj Janvier Labs RRID:MGI:2670020
Mus musculus RjOrl:SWISS Janvier Labs RRID:MGI:2168141
Recombinant DNA
SponGee This Paper N/A
Lyn-SponGee This Paper N/A
SponGee-Kras This Paper N/A
ThPDE5vv This Paper N/A
cGi500 Russwurm et al., 2007 N/A
Software and Algorithms
ImageJ Schneider et al., 2012 https://imagej.nih.gov/ij/ RRID:SCR_003070
GraphPad Prism GraphPad Software Inc. RRID:SCR_002798LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Xavier
Nicol (xavier.nicol@inserm.fr).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Pregnant C57BL6/J and RjOrl:SWISSmice and Sprague–Dawley rats were purchased from Janvier Labs. All animal procedures were
performed in accordance with institutional guidelines and approved by local ethics committees (C57BL6/J mice, C2EA-05: ComitéCell Reports 27, 4003–4012.e1–e6, June 25, 2019 e1
d’éthique en expérimentation animale Charles Darwin; Sprague–Dawley rats, ethics committee C2EA-59: Comité d’éthique en mat-
ière d’expérimentation animale Paris Centre et Sud). Animals were housed under 12 h light/12 h dark cycle. Embryos from datedmat-
ings (developmental stage stated in each section describing individual experiments) were not sexed during the experiments and the
female over male ratio is expected to be close to 1.
HEK293 Cell culture
HEK293T cells (ATCC, not authenticated, free of mycoplasma contamination) were kept in a 37C, 5% CO2 incubator and trans-
fected using Lipofectamine 2000 (Life Technologies) according to the manufacturer’s protocol and imaged the day following trans-
fection or fixed and processed for immunocytofluorescence.
METHOD DETAILS
Molecular Biology
SponGee (50-ATGAGCGAGCTGGAGGAAGACTTTGCCAAGATTCTCATGCTCAAGGAGGAGAGGATCAAAGAGCTGGAGAAGCGG
CTGTCAGAGAAGGAGGAAGAAATCCAGGAGCTGAAGAGGAAACTCCATAAATGCCAGTCAGTGCTGCCCGTGCCCTCGACCCAC
ATCGGCCCCCGGACCACCCGGGCACAGGGCATCTCGGCCGAGCCGCAGACCTACAGGTCCTTCCACGACCTCCGAGTGACCC
TGCCCTTCTACCCCAAGAGTCCACAGTCCAAGATCGATCTCATAAAGGAGGCCATCCTTGACAATGACTTTATGAAGAACTTGGAG
CTGTCACAGATCCAAGAGATTGTGGATTGTATGTACCCAGTGGAGTACGGCAAAGACAGCTGCATCATCAAAGAAGGAGATGTGG
GGTCACTGGTGTATGTCATGGAAGATGGTAAGGTTGAAGTTACAAAAGAAGGCGTGAAGCTGTGCACAATGGGTCCTGGTAAAGT
GTTTGGAGAGTTGGCTATCCTTTACAACTGTACCCGGACGGCGACCGTCAAAACTCTTGTAAATGTGAAACTCTGGGCCATTGATC
GACAATGTTTTCAGACGATAATGATGAGGACAGGACTTATCAAGCATACCGAGTATATGGAATTTTTAAAAAGCGTTCCAACATTCC
AGAGCCTTCCTGAAGAGATCCTCAGTAAACTTGCTGACGTCCTTGAAGAGACCCACTATGAAAATGGGGAATATATCATCAGGCAA
GGTGCAAGAGGGGACACCTTCTTTATCATCAGTAAAGGAAAGGTTAATGTCACTCGTGAAGACTCGCCCAATGAAGACCCAGTCT
TTCTTAGAACCTTAGGAAAAGGAGATTGGTTTGGAGAGAAAGCCTTGCAGGGGGAAGATGTGAGAACAGCGAATGTAATTGCGGC
AGAAGCTGTAACCTGCCTTGTGATCGACAGAGACTCTTTCAAACATTTGATTGGAGGATTAGATGATGTTTCTAATAAAGCATATGA
AGATGCAGAAGCTAAG-30) was designed in silico in frame with a tandem repeat of the Lyn Kinase N-terminal domain (50-ATGG
GCTGCATCAAGAGCAAGCGCAAGGACAAGATGGGCTGCATCAAGAGCAAGCGCAAGGACAAG-30) and FLAG tag in 50 of Spon-
Gee, and the desired sequences obtained as oligonucleotides from Sigma and Life Technologies, respectively. The oligos were
annealed and cloned into pcDNA3-mRFP in frame with the reporter sequence. Lipid-raft-excluded and cytosolic forms of the
SponGee variants were obtained by subcloning into pcDNA3 with or without the CaaX-polylysine motif of Kras (50-CAAGAAGAA
GAAGAAGAAGAAGAGCAAGA’), respectively. For expression on RGCs, the constructs were subcloned into pCX.
The sequence of the truncated human PDE5A1 (hPDE5) was obtained by gene synthesis in the pUC57 vector (Genscript) and
digested with SmaI and NheI enzymes (New England Biolabs). The Epac1 sequence was removed from the TEpacVV vector (obtained
from Dr Kees Jalink, NKI-AVL, Amsterdam, Netherlands) by digestion with EcoRV and NheI (New England Biolabs) and replaced
by hPDE5. The resulting final sequence of ThPDE5VV is ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCC
TGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCT
GACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGTCCTGGGGCGTGCAGT
GCTTCGCCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCA
TCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGA
AGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACATCAGCGACAACGTCTATATCACCG
CCGACAAGCAGAAGAACGGCATCAAGGCCAACTTCAAGATCCGCCACAACATCGAGGACGGCGGCGTGCAGCTCGCCGACCAC
TACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCAAGCTGAGCAA
AGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCCGATGGGAATTAGTGAAGGATATTTCTAG
TCATTTGGATGTCACAGCCTTATGTCACAAAATTTTCTTGCATATCCATGGACTGATATCTGCTGACCGCTATTCCCTGTTCCTTGTCT
GTGAAGACAGCTCCAATGACAAGTTTCTTATCAGCCGCCTCTTTGATGTTGCTGAAGGTTCAACACTGGAAGAAGTTTCAAATAAC
TGTATCCGCTTAGAATGGAACAAAGGCATTGTGGGACATGTGGCAGCGCTTGGTGAGCCCTTGAACATCAAAGATGCATATGAGG
ATCCTCGGTTCAATGCAGAAGTTGACCAAATTACAGGCTACAAGACACAAAGCATTCTTTGTATGCCAATTAAGAATCATAGGGAAG
AGGTTGTTGGTGTAGCCCAGGCCATCAACAAGAAATCAGGAAACGGTGGGACATTTACTGAAAAAGATGAAAAGGACTTTGCTG
CTTATTTGGCAGCTAGCGAGCTCATGGACGGCGGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGC
CCCGTGCTGCTGCCCGACAACCACTACCTGAGCTACCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGT
CCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGGGTGGCAGCGGTGGCATGGTGAGCA
AGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGT
CCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGCTGATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGC
CCACCCTCGTGACCACCCTGGGCTACGGCCTGCAGTGCTTCGCCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGT
CCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAG
TTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCT
GGAGTACAACTACAACAGCCACAACGTCTATATCACCGCCGACAAGCAGAAGAACGGCATCAAGGCCAACTTCAAGATCCGCCA
CAACATCGAGCCGAATTTTGTCTTCCTGATCGGCGCCGCAGGAATACTCTTCGTATCTAGCGAGCTCATGGTGAGCAAGGGCGAGe2 Cell Reports 27, 4003–4012.e1–e6, June 25, 2019
GAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGG
GCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGCTGATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCT
CGTGACCACTCTGGGCTACGGCCTACAGTGCTTCGCCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCAT
GCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGG
GCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTAC
AACTACAACAGCCACAACGTCTATATCACCGCCGACAAGCAGAAGAACGGCATCAAGGCCAACTTCAAGATCCGCCACAACATCG
AGGACGGCGGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCA
CTACCTGAGCTACCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGC
CGGGATCACTCTCGGCATGGACGAGCTGTACAAGCCGAATTCCCTCGAGGTTAACGCGGCGCGCCTCTAA.
SponGee production and purification
The full-length SponGee cDNA was subcloned into a pEXP5-NT/TOPO vector (Invitrogen V960-05) in frame with the N-terminal
peptide containing a polyhistidine (6xHis) tag. Protein was produced in Bl21-CodonPlus (DE3)-RIPL competent cells (Agilent tech-
nologies 230280). The His-tagged recombinant protein was purified using a Ni-NTA (nickel-nitrilotriacetic acid) column. It was then
eluted in a buffer containing 30mMMOPS (3-Morpholinopropanesulfonic acid), pH 7.2 and 200mMNaCl. Protein concentration was
deduced from A280 measurement using a computed extinction coefficient of 5500 M
-1 cm-1.
Fluorescence anisotropy
The dissociation constant of fluorescein-labeled cGMP (Fluo-cGMP) was measured using fluorescence anisotropy experiments
essentially as described (Kim et al., 2016). Fluo-cGMP was diluted to 3.2 nM in a final volume of 300 mL in a buffer containing
30 mM MOPS-HCl (pH 7.2), 300 mM NaCl. All measurements were performed in a Hellma 1 cm x 0.4 cm cuve at 37C with a
FP-8300 JASCO spectrofluorometer. Fluorescence anisotropy (r) was recorded at 530 nm (lexc = 485 nm). Aliquots of SPG (0.1 to
4.4 mM) were added for titration. For each titration point, 10 anisotropy measurements were recorded successively at different times
in order to verify that equilibrium has been reached. Dissociation constant was calculated from simple binding curves by non-linear
regression using Origin (OriginLab Corp., Northampton, USA), assuming one site per monomer. Results are the average ± sd from
3 independent experiments.
For themeasurement of the dissociation constant of cGMP, competition experiments were performed. Samples containing 3.2 nM
Fluo-cGMP (Biolog) and 2 mM SponGee were titrated with unlabeled. Fluorescence anisotropy was plotted as a function of cGMP
concentration and fitted as described (Maag and Lorsch, 2003; Monestier et al., 2018) by non-linear regression (Origin, OriginLab
Corp., Northampton, USA) using a quadratic equation (Weeks and Crothers, 1992).
r = rFcGMP + ½rSpG:FcGMP  rFcGMP3
½KL+KL½cGMP
KU
+ ½SpG+ ½FcGMP


ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ðKL+KL½cGMP=KU+ ½SpG+ ½FcGMPÞ2  4½FcGMP½SpG
q
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where [FcGMP] is the total concentration of fluorescent cGMP, [SpG] is the concentration of SponGee, KL is the dissociation
constant of F-cGMP from its complex with SponGee, [cGMP] is the concentration of unlabeled cGMP, KU is the dissociation
constant of cGMP from its complex with SponGee, rFcGMP is the fluorescence anisotropy of Fluo-cGMP and rSpG:FcGMP is the fluo-
rescence anisotropy of the SPG:F-cGMP complex. For all titrations, it was verified that fluorescence emission did not change upon
binding and therefore no correction for changes in quantum yield have been performed. Results are the average ± sd from 3 inde-
pendent experiments.
Cell death assay
HEK293 Cells were plated on poly-lysine-coated coverslips and transfected the next day with a pCX-mRFP or a pCX-SponGee
vector using Lipofectamine 2000 (Thermo Fisher) following themanufacturer’s instructions. Three days after plating, cells were either
fixed with 4% paraformaldehyde and processed for immunocytochemistry with the antibodies against Cleaved Caspase 3 (Asp175;
Cell Signaling; lot # 0043) and a-tubulin (Sigma) or treated with the CellEvent Caspase 3/7 Green Detection Reagent (Thermo Fisher)
for 30 min and then fixed and labeled with an a-tubulin antibody. For each experiment, the proportion of Caspase3-positive over un-
labeled cells in the population of mRFP- or SponGee-positive cells was computed from 10 randomly chosen fields acquired on a 20x
air objective in a DM6000 microscope (Leica Microsystems).
Rat hippocampal culture
Hippocampal neuronal cultures were performed essentially as described previously (Leterrier et al., 2006). Briefly, hippocampi of rat
embryos were dissected at embryonic day 18. After trypsinization, dissociation was achieved with a fire-polished Pasteur pipette.
Cells were counted and plated on poly-D-lysine-coated 18-mm diameter glass coverslips, at a density of 300–400 cells$mm-2.
The plating medium was Neurobasal (Life Technologies) supplemented with 2% B27 (Life Technologies) and containing stabilized
Glutamine (0.5 mM) and penicillin G (10 U$mL-1)/streptomycin (10 g$mL-1). Four h after plating, the coverslips were transferredCell Reports 27, 4003–4012.e1–e6, June 25, 2019 e3
into Petri dishes containing supplemented Neurobasal medium that had been conditioned for 24 h on an 80% confluent glia layer.
Neurons were transfected after 6 days in vitro (DIV) using Lipofectamine 2000 (Life Technologies), following the manufacturer’s
instructions.
EC50 and emission spectrum measurements
Cells transfected with ThPDE5VV were washed thrice with ice cold PBS and collected in 5mM Tris-HCL, 2 mM EGTA, pH = 7.3. Cells
were sonicated during 45 s on ice with a Vibra-Cell (Bioblock Scientific). Lysates were pelleted and the emission of the supernatants
was imaged with an Infinite M1000 plate reader and the software Magellan 7.2 SP1 (Tecan). For spectral emission the samples were
excited at 434/10 nm, and the emissions analyzed from 450 to 600 nm with 2nm increments, in absence or presence (200 mM). Sam-
ples were mixed with standardized dilutions of cAMP and cGMP (Biolog) and the ratio of emissions at 480 nm over 540 nmwas used
to calculate the EC50 of the sensor in GraphPad Prism (GraphPad Software Inc.).
Membrane fractionation by detergent-free method
Membrane fractionation was performed as described previously (Averaimo et al., 2016). Electroporated retinas were pelleted (195 g
for 5 min at 4C) and resuspended in 1.34 mL of 0.5 M sodium carbonate, pH 11.5, with protease inhibitor cocktail and phosphatase
inhibitor cocktail 1, 2 and 3 (Sigma-Aldrich). The homogenate was sheared through a 26-gauge needle and sonicated three times for
20 s bursts. The homogenate was adjusted to 40% sucrose by adding 2.06mL of 60% sucrose inMBS (25mMMES, pH 6.4, 150mM
NaCl, and 250 mM sodium carbonate), placed under a 5%–30% discontinuous sucrose gradient, and centrifuged at 34,000 rpm for
15–18 h at 4C in a Beckman SW 41Ti rotor. Nine fractions (1.24 mL each) were harvested from the top of the tube, mixed with 9 vol-
umes of MBS, and centrifuged at 40,000 rpm for 1 h at 4C (Beckman SW-41Ti rotor). Supernatants were discarded, and membrane
pellets were resuspended in 100 ml of 1% SDS.
Immunoblotting
For immunoblotting, samples were separated on 4%–15% Mini- Protean TGX Tris-Glycine-buffer SDS-PAGE (Biorad) and trans-
ferred onto 0.2 mm Trans-Blot Turbo nitrocellulose membranes (Biorad). Membranes were blocked for 1 h at room temperature in
1xTBS (10 mM Tris pH 8.0, 150 mM NaCl,) supplemented with 5% (w/v) dried skim milk powder. Primary antibody incubation
was carried out overnight at 4C, with the following antibodies: rabbit anti-DsRed (1/200; 632476; Clontech; lot # 1306037), rabbit
anti-b-Adaptin (1/200; sc-10762; Santa Cruz; lot # E1304) and rabbit anti-Caveolin (1/500; 610060; BD Transduction Laboratories;
lot # GR256941). All primary antibodies have been previously validated for this assay (Averaimo et al., 2016). A goat anti-rabbit-
HRP coupled secondary antibody was used for detection (Jackson ImmunoResearch, West Grove, PA). After antibody incubations,
membranes were extensively washed in TBS T (TBS containing 2.5% Tween-20). Western blots were visualized using the enhanced
chemiluminescence method (ECL prime Western Blotting detection reagent, Amersham).
Expression of Guanylate Cyclases
In order to evaluate the endogenous expression of sGCs in HEK293T cells, total cellular proteins were extracted in lysis buffer (10mM
HEPES pH 7, 100 mM NaCl, 2 mM EDTA, 0.5% NP-40) supplemented with protease inhibitor cocktail and phosphatase inhibitor
cocktails 1 and 3 (Sigma-Aldrich). Proteins were separated, transferred, incubated with mouse anti-GUCY1A3 (1/500; MA5-
17086; Thermofisher Scientific; lot # TJ2659608) or rabbit anti-GUCY1B3 (1/500; PA5-42803; Thermofisher Scientific; lot
# TJ266011) antibodies and visualized as described above using goat anti-mouse or goat anti-rabbit HRP as secondary antibodies
and ECL Prime for the detection.
Assessment of SponGee dimerization
To explore the possibility of expression of Spongee as monomers or dimers, cellular extracts of HEK293T cells expressing SponGee
were analyzed by SDS-PAGE under non-reducing (DTT free) or reducing condition (addition of 5 mMDTT) then transferred and incu-
bated with rabbit anti-DsRed antibody (1/200; 632496; Clontech; lot # 1306037) and revealed as described before.
VASP phosphorylation experiments
For phosphorylation studies, HEK293T cells were transfected or not with SponGee vectors for 24 h after plating using Lipofectamine
2000 according to the manufacturer’s instructions (Invitrogen). For stimulation, cells were incubated for 5 min with 50 mM Spermine-
NONOate or vehicle at 37C in the presence or not of ODQ. In this case, 30 min before stimulation with Spermine-NONOate, vehicle
solution or ODQ 100mM (R&D Systems) was applied. NO stimulation reaction was stopped by placing cells on ice followed by extrac-
tion of proteins described before. Samples were then separated andmembranes incubated with rabbit anti-phospho-VASP (Ser239)
(1/500; 3114; Cell Signaling; lot # 7) or rabbit anti-VASP (1/500; 3132. Cell Signaling; lot # 4) and visualized with goat anti-rabbit HRP
as secondary antibodies and ECL Prime for the detection.
In utero electroporation
Timed pregnant females (Janvier Labs) were delivered to the animal facility a week prior to the surgery in order to allow a minimum
of 5-days adaptation. In utero electroporation was performed as described previously (Loulier et al., 2009). E14.5 females weree4 Cell Reports 27, 4003–4012.e1–e6, June 25, 2019
anesthetized with Ketamine/Xylazine and a midline laparotomy was performed, exposing uterine horns and allowing visualization of
embryos under oblique illumination. 1 mL of DNA containing two plasmids vectors combined 3:1 with sterile Fast Green dye (Sigma)
was injected with a glass capillary pipette (75–125 mm outer diameter with beveled tip) driven by a INJECT+MATIC (INJECT+MATIC)
microinjector into the lateral ventricle of each embryo. Two different plasmid vectors were injected simultaneously. The first was a
plasmid encoding green fluorescent protein under the control of the chicken beta actin promoter (pCX-eGFP), used as a control
of electroporation. The second was either a plasmid encoding red fluorescent protein (mRFP) control construct or SponGee-
mRFP. The anode of 5 mm diameter tweezertrodes (Sonidel Limited) was placed above the dorsal telencephalon and four 35-V
pulses of 50ms duration were applied across the uterine sac. Following intrauterine surgery, the incision site was closed with sutures
(4-0, Ethicon) and the mouse was allowed to recover in a clean cage. Mice were either euthanized 4 days after surgery to harvest
E18.5 embryonic brains, or allowed to give birth for analysis at P10 postnatal stage. Embryonic brains were dissected out, immersed
overnight in Antigenfix (Diapath) fixative solution and rinsed in PBS prior to sectioning. P10 mice were deeply anesthetized with so-
dium pentobarbital (150 mg$kg-1), perfused transcardially with Antigenfix (Diapath), brains dissected out and postfixed overnight in
the same solution. Embryonic and postnatal brain sampleswere sectioned at 200 mm thickness on a vibrating blademicrotome (Leica
VT 1000S). Finally, sections were either mounted in Vectashield+Dapi (Vector laboratories) or incubated 2 h in 10 mg$mL-1 bis-ben-
zimide (Sigma Aldrich) andmounted in Mowiol 4-88 (Sigma Aldrich). Confocal images were acquired with a 60X oil-immersion objec-
tive (N.A. 1.4) and a Z stack containing the whole specimen was sampled at Nyquist frequency in an Olympus FV1000 confocal
microscope. Images were rendered in ImageJ and Photoshop.
Collapse assay
Retinas of E14 mouse embryos were electroporated with mRFP, Lyn-SponGee, SponGee or SponGee-Kras using two poring pulses
(square wave, 175V, 5ms duration, with 50ms interval) followed by four transfer pulses (40V, 50 ms duration and 950 ms interpulse
interval) with a Nepa21 Super Electroporator (NepaGene). Retinas were dissected and kept 24 h in culture medium (DMEM-F12
supplemented with glutamine (Sigma Aldrich), penicillin/streptomicin (Sigma Aldrich), BSA (Sigma Aldrich) and glucose, in a
humidified incubator at 37C and 5% CO2. The day after, they were cut into 200 mm squares with a Tissue-Chopper (McIlwan)
and explants were plated on glass coverslips coated with poly- lysine and Laminin (Sigma Aldrich). Cells were cultured for 24 h in
culture medium supplemented with 0.4% methyl cellulose and B-27 (Life Technologies) and treated with 200 ng$mL-1 rmSlit1 or
500 ng$mL-1 rmEphrinA5 (R&D Systems) for 1 h.
Immunostaining
Retinal explants, or HEK cells coexpressing the targeted versions of SponGee and GFP, were fixed with 4% PFA in PB for 30 min,
permeabilized and blocked and with 1% Triton and 3% BSA in PBS, then incubated with antibodies against DsRed (632496,
Clontech, lot # 1306037, previously used in a similar assay, (Averaimo et al., 2016) followed by a secondary antibody coupled to
AlexaFluor 594 (A21207, Life Technologies, lot # 1602780) and GFP (A11122, Life Technologies, lot # 1789911, previously validated
in Nicol et al., 2007) or a-Tubulin (T6199, Sigma, lot # 024M4850V, previously validated in Nicol et al., 2007) followed by a secondary
antibody coupled to AlexaFluor 488 (A21202, Life Technologies, lot # 1562298).
FRET Imaging and analysis (HEK293 cells)
Imageswere acquiredwith an inverted DMI6000B epifluorescencemicroscope (Leica) coupled to a 40x oil-immersion objective (N.A.
1.3) and the software Metamorph (Molecular Devices). For live imaging experiments, cells transfected with ThPDE5VV or H147, and
co-expressing mRFP or SponGee were perfused with 1 mM CaCl2, 0.3 mM MgCl2, 0.5 mM Na2HPO4, 0.5 mM NaH2PO4, 0.4 mM
MgSO4, 4.25 mM KCl, 14 mM NaHCO3, 120 mM NaCl, 0.0004% CuSO4, 1.24 mM Fe (NO3)3, 1.5 mM FeSO4, 1.5 mM thymidine,
0.51 mM lipoic acid, 1.5 mM ZnSO4, 0.5 mM sodium pyruvate (all from Sigma), 1X MEM Amino Acids (Life Technologies), 1X non-
essential amino acids (Life Technologies), 25 mM HEPES (Sigma), 0.5 mM putrescine (Sigma), 0.01% BSA (Sigma), 0.46% glucose
(Sigma), 1 mM glutamine (Life Technologies), 2% penicillin/streptomicin (Life Technologies). Vitamin B12 and riboflavin were omitted
because of their autofluorescence. Spermine-NONOate was used at 50 mM (in the range of previous use, Huang et al., 2003), ODQ
(Tocris) at 10 mM, or at 100 mM when used in experiments where NO was to be used, and Forskolin (Sigma) at 10 mM. Images were
acquired simultaneously for the CFP (483/32 nm) and YFP (542/27) channels every 20 swhile cells were continuously superfusedwith
the medium described above. Simultaneous CFP and YFP channel acquisition was achieved using a dual chip CCD camera -D2
(Hamamatsu). The wavelength used for CFP excitation in HEK cells was 436/20 nm. Images were processed in ImageJ, corrected
for background and bleedthrough from CFP into the YFP channel. The ratio YFP:CFP (ThPDE5VV) or CFP:YFP (H147 and cGI500)
was computed and normalized to the initial values for each single cell.
FRET imaging (rat hippocampal cultures)
Neurons transfected with ThPDE5VV probe were imaged by videomicroscopy between DIV8 and DIV11 on amotorized Nikon Eclipse
Ti-E/B inverted microscope with the Perfect Focus System (PFS) in a 37C thermostated chamber, using an oil immersion CFI Plan
APOVC 60x, NA 1.4 objective (Nikon). Acquisitions were carried out at the excitation wavelength of the CFP (434nm ± 15nm) using an
Intensilight (Nikon). Emitted light passed through anOptosplit II beam-splitter (Cairn Research) equippedwith a FF509-FDi01 dichroı̈c
mirror, a FF01-483/32-25 CFP filter and a FF01-542/27-25 YFP filter and was collected by an EM-CCD camera (Evolve 512,Cell Reports 27, 4003–4012.e1–e6, June 25, 2019 e5
Photometrics), mounted behind a 2x magnification lens. Acquisitions were performed by piloting the set-up with Metamorph 7.7
(Molecular Devices). All filter sets were purchased from Semrock. Cultured neurons on 18-mm coverslips were placed in a closed
imaging chamber containing an imaging medium: 120 mM NaCl, 3 mM KCl, 10 mM HEPES, 2 mM CaCl2, 2 mM MgCl2, 10 mM
D-glucose, 2% B27, 0,001% BSA. The acquisition lasted 70 min registering one image every 2 min, registering in parallel 4 to 6 neu-
rons on the same coverslip. 30min after the beginning of the acquisition, vehicle solution or ODQ 100 mM (R&D Systems) was applied
40 min after the onset of acquisition, DEA NONOate (Sigma) 50mM or Forskolin (Sigma) 10mM was applied.
FRET data analysis (rat hippocampal culture)
Imageswere divided in two parts on ImageJ to separate the CFP channel from the YFP channel. Datawere then analyzed onMATLAB
by calculating the FRET ratio at each time point for one or several Regions Of Interest (ROIs). The user defined ROIs for each position.
For each image, the value of the FRET ratio corresponds toðIY BY=IC BCÞ, where IY is the mean intensity of the ROI in the YFP
channel; BY is the mean intensity of the background in the YFP channel; IC is the mean intensity of the ROI in the CFP channel; BC is
the value of the background in the CFP channel. For each ROI, the FRET ratio was then normalized by the baseline mean, defined as
the 7 time points before first treatment injection. FRET Ratio = 100  ðRcRo=RoÞ, where Rc is the value of the crude FRET ratio and
Ro is the mean of the baseline. The quantitative results obtained for each neuronal compartment were grouped together and the
mean FRET ratio normalized to baseline and SEMwere calculated for each time point. Deviation was corrected for somata and den-
drites onMATLAB. Themean slope was calculated for all neurons in the somata and dendrites, respectively, for the last 7 time points
before addition of treatment and subtracted from all FRET ratio time points.
Imaging of SponGee targeting
Confocal images were acquired with a 63x oil immersion objective (N.A. 1.45) and a Z stack containing the whole specimen was
sampled at Nyquist frequency in an Olympus confocal microscope (FV1000). Images were rendered in ImageJ and Photoshop.
QUANTIFICATION AND STATISTICAL ANALYSIS
No data were excluded from the analysis. No sample size calculation was performed. Sample size was considered sufficient after
three reproducible and independent experiments, leading to n R 3 since several animals, coverslips, or biochemical assays were
often analyzed for the same experimental condition. Animals or cultures were equivalent and not distinguishable one from another
before treatment, de facto randomizing the sample without the need of a formal randomization process. Photomicrographs were
often easily traceable by eye to its experimental condition, making blind analysis of the data difficult to achieve. When careful blinding
was performed, experiments reproduced the results obtained in non-blinded experiments with identical experimental conditions.
Image calculation and analysis were performed using ImageJ, except for the validation of the ThPDE5VV sensor in hippocampal neu-
rons for which MATLAB was used.
Statistical tests were calculated using GraphPad Prism (GraphPad Software Inc.). Table S1 summarizes the p values and number
of replicates.e6 Cell Reports 27, 4003–4012.e1–e6, June 25, 2019
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Figure S1. Validation of the ThPDE5VV biosensor. Related to Figure 2. (A) The emission spectrum of 
ThPDE5VV measured from lysates of HEK cells overexpressing the sensor in the absence or presence of cGMP 
(200 µM).  (B) Concentration-response curves of ThPDE5VV. EC50 values are 0.32 ± 0.09 µM for cGMP and 
1.6 ± 0.7 mM for cAMP (mean ± S.E.M.). Rat hippocampal cultured neurons were transfected with ThPDE5VV 
and imaged using FRET videomicroscopy. Addition of DEA-NONOate 50 μM induced a strong increase of 
the FRET ratio both in (C) the soma and (D) axon compared to their respective baselines. In contrast, the 
adenylyl cyclase activator Forskolin (Fsk, 50 µM) did not induce any FRET elevation. Preincubation of the 
guanylyl cyclase inhibitor ODQ (100 µM, 10 min before 50 μM DEA-NONOate) blocked the elevation of 
FRET induced by the NO donor. Representative traces are shown. Data are mean ± s.e.m with individual data 
points, ** P < 0.01, *** P < 0.001. (A) Kruskal-Wallis test and individual Mann-Whitney tests. (B) Mann-
Whitney test. Scale bars, 10 µm. Exact P values and number of replicates are provided in Table S1. 
  
Figure S2. NO-exposed HEK293 cells activate cGMP-dependent signaling and induce sGC-dependent 
FRET change detected using two distinct FRET sensors. Related to Figure 2. (A) Antibodies directed 
against the α1 and β1 subunits of soluble guanylyl cyclase 1 (sGC1) detected both subunits in HEK293 
cellular extracts. (B) In HEK293 cells, NO (Spermine-NONOate 50µM) induced an elevation of the 
phosphorylated form of VASP at Serine 239, a downstream effector of cGMP. This elevation is reduced by 
the soluble guanylyl cyclase inhibitor ODQ (100 µM). (C,D) A 1-minute pulse of 50 µM Spermine-NONOate 
(NO) induces an elevation of the FRET:CFP ratio of ThPDE5VV that was blocked by the sGC inhibitor ODQ 
(100 µM). (E,F) Likewise, a second cGMP FRET probe, cGi500, detected a NO-dependent increase in the 
CFP:FRET ratio in HEK293. (F) cGi500 response to a short pulse of NO was reduced as compared to 
ThPDE5VV. (E,G) The reversibility of the ratio FRET change was incomplete when using cGi500, in contrast 
to ThPDE5VV. (G) Quantification of the FRET change after NO washout. (B) Data are mean ± s.e.m with 
individual data points, * P < 0.05, one-way ANOVA and Newman-Keuls post hoc tests. (C,E) Data are mean 
± s.e.m. (D,F,G) Box-and-whisker plot elements: center line, mean; box limits, upper and lower quartiles; 
whiskers, s.d.; Mean values for single coverslips (circles) are shown to check for nesting effects. Mann-
Whitney test, *** P < 0.001. Exact P values and number of replicates are provided in Table S1. Data shown in 
Figure 2B,C are included here for additional comparisons. CFP and YFP traces together with individual cell 
examples are provided in Figure S7. 
 
 
  
Figure S3. Buffering of NO-induced cGMP elevation by SponGee is detected by cGi500 and is efficient 
from low levels of expression. Related to Figure 2. (A) Cells co-expressing cGi500 and either mRFP or 
SponGee were challenged with a 1-minute pulse of Spermine-NONOate (50 µM), followed by a sustained 
exposure. (B) SponGee-expressing cells exhibited a reduced response amplitude and rate of elevation of 
intracellular cGMP concentration. (C) The amplitude of cGMP elevation (change in the FRET:CFP or 
CFP:FRET ratio for ThPDE5VV and cGi500 respectively) induced by a 1-minute pulse of Spermine-NONOate 
(50 µM) is plotted against the red fluorescence intensity of mRFP- or SponGee-expressing cells. In the vast 
majority of SponGee-expressing cells, the amplitude of the elevation in the ratio is smaller than the mean 
response of the mRFP-expressing cells (dashed line). These observations do not rely on the use of a specific 
FRET sensor and are reproduced for ThPDE5VV (top) and cGi500 (bottom). (A) Data are mean ± s.e.m. (B) 
Box-and-whisker plot elements: center line, mean; box limits, upper and lower quartiles; whiskers, s.d.; Mean 
values for single coverslips (circles) are shown to check for nesting effects. Mann-Whitney test, *** P < 
0.001. Exact P values and number of replicates are provided in Table S1. Data shown in Figure S2 are 
included here for additional comparisons. CFP and YFP traces together with individual cell examples are 
provided in Figure S7.  
Figure S4. Biochemical characterization of the SponGee targeting. Related to Figure 7. Lyn-SponGee is 
enriched in fraction 4 on a membrane fractionation assay. (A) It coincides with the expression profile of the 
lipid raft-targeted protein caveolin and (B) differs from the submembrane location of adaptin (enriched in 
fractions 7, 8 and 9), a protein excluded from lipid rafts. SponGee-Kras is enriched in fractions 7-9, with a 
profile (C) distinct from caveolin, and (D) similar to adaptin. Data are mean ± s.e.m.; * P < 0.05; ** P < 0.01; 
*** P < 0.001; Two-way ANOVA and Bonferroni post hoc tests. Exact P values and number of replicates are 
provided in Table S1. Data shown in Figure 7D are included here for additional comparisons. Individual data 
points are shown in Figure 7D when n ≤ 10. 
  
Figure S5. In RGC growth cones, SponGee buffers the ephrinA5-induced increase in cGMP. Related to 
Figure 7. (A) Control and SponGee-expressing axons were superfused with ephrinA5 (500 ng·mL-1) and 
Spermine-NONOate (50 µM), and changes in the growth cone cGMP concentration were monitored using 
ThPDE5VV. SponGee-expression reduced the increases in cGMP concentration induced by (B) ephrinA5 
(quantified as the mean amplitude from 0.7 to 2 minutes after ephrinA5 application) and (C) NO (quantified 
as the mean amplitude from 2.7 to 4 min after NO application). (A) Data are mean ± s.e.m. (B,C) Box-and-
whisker plot elements: center line, mean; box limits, upper and lower quartiles; whiskers, s.d. Mann-Whitney 
test, *P < 0.05, **P < 0.01. Exact P values and number of replicates are provided in Table S1. CFP and YFP 
traces together with individual growth cone examples are provided in Figure S7. 
  
Figure S6. Cytosolic SponGee and Lyn-SponGee but not SponGee-Kras prevent ephrinA5-induced 
growth cone collapse. Related to Figure 7. (A) SponGee, Lyn-SponGee and SponGee-Kras do not affect the 
morphology of growing axons. Non-electroporated (Ctrl) RGC axons display a fan-shaped growth cone at 
their tip which is not affected by the expression of mRFP, SponGee, Lyn-SponGee or SponGee-Kras. When 
exposed to (B-E) 500 ng·mL-1 ephrinA5 or (F-I) 200 ng·mL-1 slit1, mRFP-expressing growth cones exhibit 
the same collapse response than their non-electroporated neighbors of the same coverslips, (C, G) SponGee- 
and (D, H) Lyn-SponGee-expressing axons are resistant to the repellent activity of ephrinA5 and slit1, that is 
observed in the non-electroporated axons from the same coverslip. (E, I) In contrast, SponGee-Kras-
expressing axons exhibit similar growth cone remodeling to their controls. Box-and-whisker plot elements: 
center line, mean; box limits, upper and lower quartiles; whiskers, s.d. Individual data points are shown. Scale 
bar, 10 µm. (A) No significant differences are detected; Kruskall-Wallis test. (B-I) * P < 0.05; *** P < 0.001; 
Wilcoxon paired test. Exact P values and number of replicates are provided in Table S1. (A) A subset of the 
data shown in Figure 7E,F are included here for additional comparisons. (B-I) A subset of the data shown in 
Figure 7E,F are included here for additional comparisons with control growth cones from the same coverslips. 
Figure S7. Individual CFP, YFP and Ratio traces. Related to Figure 2, 3, 5, S2, S3 and S5.Average and 
individual example traces for CFP (blue), YFP (yellow) and ratio are shown for a 1 minute- stimulation of NO 
using (A) ThPDE5VV (with and without SponGee) or (B) cGi500 (with and without SponGee), (C) 2 minute- 
stimulation of NO (using the ThPDE5VV biosensor, with and without SponGee) (D) 1 minute- stimulation of 
NO alone and in combination with ODQ (using the ThPDE5VV biosensor), (E) a 20 second-stimulation of Fsk 
using H147 (with and without SponGee), (F) a 1 minute- stimulation of NO in combination with a sham 
exposure (using the ThPDE5VV biosensor, with and without SponGee), (G) a 1 minute- stimulation of NO in 
combination with a sustained Fsk exposure (using the ThPDE5VV biosensor, with and without SponGee) and 
(H) an ephrin-A5 stimulation followed by a NO exposure (using the ThPDE5VV biosensor, with and without 
SponGee). (A-G) HEK293 cells; (H) retinal ganglion cells growth cones. 
